BioCentury | Jul 26, 2019
Company News

July 25 Company Quick Takes: RegenxBio, Neurimmune in neurodegenerative gene therapy deal; plus Lilly, Epizyme, ElevateBio and more

...be pushed back. FDA declined to comment. NeuroBo to become public via merger with Gemphire NeuroBo Pharmaceuticals Inc....
...BIBF 1120, ofev, BIBF1120) Boehringer Ingelheim GmbH ElevateBio LLC Eli Lilly and Co. Epizyme Inc. Gemphire Therapeutics Inc. Massachusetts General Hospital Nektar Therapeutics NeuroBo Pharmaceuticals Inc. RegenxBio...
Items per page:
1 - 1 of 1
BioCentury | Jul 26, 2019
Company News

July 25 Company Quick Takes: RegenxBio, Neurimmune in neurodegenerative gene therapy deal; plus Lilly, Epizyme, ElevateBio and more

...be pushed back. FDA declined to comment. NeuroBo to become public via merger with Gemphire NeuroBo Pharmaceuticals Inc....
...BIBF 1120, ofev, BIBF1120) Boehringer Ingelheim GmbH ElevateBio LLC Eli Lilly and Co. Epizyme Inc. Gemphire Therapeutics Inc. Massachusetts General Hospital Nektar Therapeutics NeuroBo Pharmaceuticals Inc. RegenxBio...
Items per page:
1 - 1 of 1